Thethi, T. K., Pratley, R., & Meier, J. J. (2020). Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme. Diabetes Obes Metab.
Παραπομπή Chicago StyleThethi, Tina K., Richard Pratley, και Juris J. Meier. "Efficacy, Safety and Cardiovascular Outcomes of Once‐daily Oral Semaglutide in Patients With Type 2 Diabetes: The PIONEER Programme." Diabetes Obes Metab 2020.
Παραπομπή MLAThethi, Tina K., Richard Pratley, και Juris J. Meier. "Efficacy, Safety and Cardiovascular Outcomes of Once‐daily Oral Semaglutide in Patients With Type 2 Diabetes: The PIONEER Programme." Diabetes Obes Metab 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.